Combination Low-Dose Tissue-Type Plasminogen Activator Plus Annexin A2 for Improving Thrombolytic Stroke Therapy

Risk of hemorrhagic transformation, incomplete reperfusion, neurotoxicity, and a short treatment time window comprises major challenges for tissue plasminogen activator (tPA) thrombolytic stroke therapy. Improving tPA therapy has become one of the highest priorities in the stroke field. This mini re...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Front Cell Neurosci
Hoofdauteurs: Jiang, Yinghua, Fan, Xiang, Yu, Zhanyang, Liao, Zhengbu, Wang, Xiao-Shu, van Leyen, Klaus, Sun, Xiaochuan, Lo, Eng H., Wang, Xiaoying
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2015
Onderwerpen:
Neuroscience
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4604305/
https://ncbi.nlm.nih.gov/pubmed/26528130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fncel.2015.00397
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items